Status:
WITHDRAWN
Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborating Sponsors:
Dana S Hardin
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
6-40 years
Phase:
NA
Brief Summary
We hypothesize that the anabolic effects of growth hormone (GH) will improve the clinical status of patients with CF by improving lean body mass, osteopenia, muscle strength, pulmonary function, and q...
Detailed Description
Patients will be treated with growth hormone in the form of Nutropin (a powder formulation that is reconstituted by the patient) or Nutropin AQ (a ready-to-use liquid) for 1 year. Both of these produc...
Eligibility Criteria
Inclusion
- Age 6 - 40 years
- less than 100% of ideal body weight.
Exclusion
- Colonization with Burkholderia cepacia
- pregnancy.
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00287430
Start Date
January 1 2006
End Date
January 1 2006
Last Update
March 12 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.